Abbott Strikes Back At Bayer Patent Suit Over Humira

Law360 (January 6, 2009, 12:00 AM EST) -- Abbott Laboratories has sued Bayer HealthCare LLC for a judgment that a Bayer patent is invalid and unenforceable, firing back at an infringement suit Bayer filed recently seeking to assert the patent against Abbott's hugely popular arthritis drug Humira.

In a complaint filed Monday in the U.S. District Court for the District of Massachusetts, Abbott asked for a declaration that Humira does not infringe U.S. Patent Number 5,654,407, titled “Human anti-TNF antibodies,” and that the '407 patent is invalid and unenforceable under the doctrine of laches,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.